Supplementary Figure S4: Timing of post-ipilimumab biopsy does not impact immune infiltration from Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3&lt;sup&gt;+&lt;/sup&gt; Regulatory T Cells (Tregs) in Human Cancers